Article
A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI.
Indian heart journal - 1 Jan 2000
Rath P C, Chidambaram Sundar, Rath Pallavi, Dikshit Byomakesh, Naik Sudhir, Sahoo Prashant K, Das Brajraj, Mahalingam Mohanshankar, Khandrika Lakshmipathi, Jain Jugnu
Abstract excerpt
BACKGROUND: A thorough understanding of the patient's genotype and their functional response to a medication is necessary for improving event free survival. Several outcome studies support this view particularly if the patient is to be started on clopidogrel due to the prevalence of clopidogrel resistance. Such guided therapy has reduced the incidence of Major Adverse Cardiac Events (MACE) after stent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
